Hypertension — Reducing Cardiovascular Risk in Primary Care: a Randomized Clinical Trial
Citation(s)
Alvarado L [Adherence to treatment in chronic diseases and the patient's experience]. Rev Med Chil. 2016 Feb;144(2):269-70. doi: 10.4067/S0034-98872016000200019. Spanish.
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P; CONSORT NPT Group CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med. 2017 Jul 4;167(1):40-47. doi: 10.7326/M17-0046. Epub 2017 Jun 20.
Du L, Cheng Z, Zhang Y, Li Y, Mei D The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis. Eur J Prev Cardiol. 2017 Jun;24(9):962-970. doi: 10.1177/2047487317695628. Epub 2017 Jan 1. Review.
Fernando L, Pamela S, Alejandra L Cardiovascular disease in Latin America: the growing epidemic. Prog Cardiovasc Dis. 2014 Nov-Dec;57(3):262-7. doi: 10.1016/j.pcad.2014.07.007. Epub 2014 Aug 4.
Kripalani S, Risser J, Gatti ME, Jacobson TA Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health. 2009 Jan-Feb;12(1):118-23. doi: 10.1111/j.1524-4733.2008.00400.x.
Serón P, Muñoz S, Lanas F [Levels of physical activity in an urban population from Temuco, Chile]. Rev Med Chil. 2010 Oct;138(10):1232-9. doi: /S0034-98872010001100004. Epub 2011 Jan 10. Spanish.
Valencia-Monsalvez F, Mendoza-Parra S, Luengo-Machuca L [Evaluation of Morisky medication adherence scale (mmas-8) in older adults of a primary health care center in Chile]. Rev Peru Med Exp Salud Publica. 2017 Apr-Jun;34(2):245-249. doi: 10.17843/rpmesp.2017.342.2206. Spanish.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
